| Particulars |
|
|
|
|
Company Name
| Gland Pharma Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
16.50 |
B.V. (₹) |
655.30 |
| Sales(₹ Cr.) |
4,552.09 |
NP (₹ Cr.) |
1,315.23 |
| NP Var% |
21.00 |
Div% |
2,000.00 |
| CPS(₹) |
90.40 |
EPS (₹) |
79.70 |
| Traded Value(₹ Lakhs) |
2,235.27 |
52 Week High |
2,989.00 |
| 52 Week Low |
1,575.00 |
Price BSE |
2,967.00 |
| Price NSE |
2,968.00 |
Market Capital (₹ Cr.) |
48,943.96 |
| P/C Ratio |
32.80 |
P/E Ratio |
37.20 |
| Price Vs.BV |
4.53 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
1,286.64 |
| NP(₹ Cr.) |
364.39 |
NP Var % |
35.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
4,347.71 |
| OPM |
34.13 |
NP |
1,102.85 |
| NP Var% |
24.33 |
EPS |
85.62 |
| PE |
34.65 |
|
|